Saturday 17 October 2026
Export SPRC’s income statement to Excel — free account
SciSparc Ltd.
SPRC Healthcare Biotechnology
SciSparc Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $856,000.00, down 34.5% from fiscal 2024. Operating cash flow growth for three consecutive years.
1.70
0.30
−15.00%
Follow SPRC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | — | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Altman Z-Score |
(18.65) | (10.75) | (9.07) | (10.32) | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(39.74) | (17.84) | (14.95) | (22.94) | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Beneish M-Score |
(9.26) | (0.84) | (1.04) | — | — | — | — | — | — | — |
P/Operating CF |
(23.01) | (108.33) | (1,216.19) | (4,566.10) | — | — | — | — | — | — |
P/B ratio |
0.00 | 27.50 | 496.49 | 1,959.13 | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 42.13 | 1,460.59 | 7,294.69 | — | — | — | — | — | — |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
(5.65) | (30.58) | (253.63) | (973.25) | — | — | — | — | — | — |
EV/FCF |
(5.68) | (30.72) | (254.15) | (975.28) | — | — | — | — | — | — |
Quick Ratio |
2.18 | 5.28 | 3.63 | 0.92 | 5.59 | 2.25 | 0.91 | 0.42 | 8.07 | 1.20 |
Current Ratio |
2.41 | 5.36 | 4.10 | 1.09 | 5.59 | 2.25 | 0.91 | 0.54 | 8.07 | 1.20 |
Net Debt/EBITDA |
0.52 | 0.87 | 0.76 | 0.45 | 1.20 | 0.57 | 0.21 | 0.06 | 1.60 | 0.34 |
Debt/Assets |
4.67% | 3.30% | 3.05% | 0.25% | 0.45% | 7.34% | 5.81% | 23.16% | 0.00% | 0.00% |
Debt/Equity |
0.07 | 0.04 | 0.04 | 0.00 | 0.01 | 0.13 | 4.79 | 13.71 | 0.00 | 0.00 |
Asset Turnover |
0.10 | 0.12 | 0.26 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.34 | 0.81 | 1.15 | 3.05 | 0.87 | 1.24 | 0.98 | 0.84 | 0.73 | 0.74 |
Capex/Depreciation |
0.00 | 0.02 | 0.00 | (26.04) | (1.06) | 0.00 | 4.04 | 0.18 | (8.40) | (1.00) |
Interest Coverage |
(1.02) | (20.73) | (6.46) | (4.11) | (274.67) | (3.78) | (6.08) | (59.84) | (11.72) | (250.00) |
| (172.92%) | (67.84%) | (63.88%) | (35.53%) | (120.97%) | (482.27%) | (10,536.26%) | (201.35%) | (139.34%) | (44.48%) | |
| (135.56%) | (58.38%) | (47.02%) | (25.26%) | (92.79%) | (187.46%) | (167.80%) | (120.67%) | (115.51%) | (320.16%) | |
ROIC |
(586.74%) | (153.49%) | (88.98%) | (182.24%) | (284.76%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(380.36%) | (101.96%) | (102.81%) | (630.66%) | (70.95%) | (243.50%) | (5,707.14%) | (15,783.33%) | (74.60%) | (1,393.71%) |
Average Days of Receivables |
127.49 | 304.35 | 71.25 | 56.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
244.98% | 130.70% | 57.00% | 208.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
850.82% | 462.56% | 219.80% | 483.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.15 | 0.14 | 0.29 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
101.29% | 43.57% | 6.81% | 66.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.06) | 0.01 | 0.00 | 0.00 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(582.19%) | (104.73%) | (7.41%) | (1.70%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(17.96%) | (3.22%) | (0.39%) | (0.10%) | — | — | — | — | — | — |
Revenue per Share |
6.89 | 42.40 | 1,308.64 | 1,496.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(33.31) | (165.71) | (2,675.91) | (8,796.67) | (12,652.50) | (43,070.00) | 0.00 | (2.04) | (1.57) | (1.57) |
Capex per Share |
0.00 | 0.26 | 0.00 | (5,410.00) | (87.50) | 0.00 | 0.00 | 0.01 | (0.01) | 0.00 |
Free Cash Flow per Share |
(33.31) | (165.45) | (2,675.91) | (14,206.67) | (12,740.00) | (43,070.00) | 0.00 | (2.03) | (1.58) | (1.58) |
Cash per Share |
37.13 | 204.58 | 2,336.82 | 4,037.78 | 17,300.00 | 19,560.00 | 0.00 | 0.43 | 3.16 | 0.73 |
Shareholders Equity per Share |
41.44 | 290.23 | 4,357.73 | 7,165.56 | 20,352.50 | 14,300.00 | 0.00 | 0.02 | 2.87 | 0.61 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
41.44 | 290.23 | 4,357.73 | 7,165.56 | 20,352.50 | 14,300.00 | 0.00 | 0.02 | 2.87 | 0.61 |
Free Cash Flow |
(4.14) | (5.10) | (5.89) | (12.79) | (5.10) | (4.31) | (3.97) | (7.10) | (4.62) | (1.48) |
Working Capital |
3.18 | 6.10 | 4.87 | 0.35 | 8.07 | 1.42 | (0.09) | (2.05) | 8.32 | 0.13 |
Capital Expenditures |
— | 0.01 | — | (4.87) | (0.03) | — | 0.72 | 0.03 | (0.04) | 0.00 |
Net Current Asset Value |
2.96 | 6.10 | 4.85 | 0.35 | 8.05 | 1.42 | (0.18) | (2.05) | 8.32 | 0.13 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.00 | (0.01) | 0.00 | 3.61 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
12.32 | 8.17 | 4.98 | 3.28 | 0.36 | 14.91 | 1.02 | 0.07 | 0.10 | 0.36 |
Cash ROIC |
(40.90%) | (32.71%) | (39.07%) | (126.47%) | (33.73%) | (120.51%) | (413.42%) | (270.36%) | (26.24%) | (117.30%) |
Accounts Receivable Turnover |
1.23 | 1.58 | 7.48 | 0.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.28 | 0.99 | 0.68 | 0.27 | 0.04 | 0.23 | 0.14 | 0.11 | 0.01 | 0.00 |
Inventory Turnover |
2.39 | 1.87 | 0.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
1,270.20 | 372.30 | 428.59 | 1,359.11 | 13,261.67 | 1,237.44 | 1,761.79 | 4,017.48 | 74,241.00 | 0.00 |
Days of Inventory on Hand |
121.67 | 51.56 | 396.53 | 757.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
0.69 | 0.83 | 0.39 | 1.56 | 1.75 | 0.33 | 0.24 | 0.34 | 0.20 | 0.08 |
Average Payables |
0.80 | 0.81 | 1.00 | 1.20 | 0.88 | 0.71 | 1.24 | 1.32 | 0.80 | 0.24 |
Average Inventory |
0.09 | 0.43 | 0.71 | — | — | — | — | — | — | — |
Average Assets |
8.98 | 10.76 | 10.89 | 10.26 | 6.24 | 1.86 | 2.86 | 7.06 | 5.41 | 0.62 |
Average Common Equity |
7.04 | 9.26 | 8.02 | 7.30 | 4.79 | 0.72 | 0.05 | 4.23 | 4.48 | 4.48 |
Columns are period end dates · fundamentals updated 2 Oct 2026